scholarly journals Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases

2010 ◽  
Vol 64 (1) ◽  
pp. 75-82 ◽  
Author(s):  
R. Tognon ◽  
E. P. L. Gasparotto ◽  
J. M. G. Leroy ◽  
G. L. V. Oliveira ◽  
R. P. Neves ◽  
...  
Keyword(s):  
Differential Expression ◽  
Death Receptor ◽  
Death Receptor Pathway ◽  
Myeloproliferative Diseases ◽  
Chronic Myeloproliferative Diseases

Cutaneous ulcers following hydroxyurea therapy

Phlebologie ◽  
2004 ◽  
Vol 33 (06) ◽  
pp. 202-205 ◽  
Author(s):  
K. Hartmann ◽  
S. Nagel ◽  
T. Erichsen ◽  
E. Rabe ◽  
K. H. Grips ◽  
...  
Keyword(s):  
Side Effects ◽  
Side Effect ◽  
Antineoplastic Agent ◽  
Limited Time ◽  
Myeloproliferative Diseases ◽  
Dermatological Side Effects ◽  
Chronic Myeloproliferative Diseases ◽  
Hydroxyurea Therapy

SummaryHydroxyurea (HU) is usually a well tolerated antineoplastic agent and is commonly used in the treatment of chronic myeloproliferative diseases. Dermatological side effects are frequently seen in patients receiving longterm HU therapy. Cutaneous ulcers have been reported occasionally.We report on four patients with cutaneous ulcers whilst on long-term hydroxyurea therapy for myeloproliferative diseases. In all patients we were able to reduce the dose, or stop HU altogether and their ulcers markedly improved. Our observations suggest that cutaneous ulcers should be considered as possible side effect of long-term HU therapy and healing of the ulcers can be achieved not only by cessation of the HU treatment, but also by reducing the dose of hydroxyurea for a limited time.

Lead induces apoptosis in mouse TM3 Leydig cells through the Fas/FasL death receptor pathway

2017 ◽  
Vol 56 ◽  
pp. 99-105 ◽  
Author(s):  
Xiuyuan He ◽  
Jing Wu ◽  
Liyun Yuan ◽  
Feng Lin ◽  
Jine Yi ◽  
...  
Keyword(s):  
Leydig Cells ◽  
Death Receptor ◽  
Death Receptor Pathway

scholarly journals Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression

2018 ◽  
Vol 11 (4) ◽  
pp. 354-359
Author(s):  
LA Kesaeva ◽  
◽  
EN Misyurina ◽  
DS Mar’in ◽  
EI Zhelnova ◽  
...  
Keyword(s):  
Myeloproliferative Diseases ◽  
Chronic Myeloproliferative Diseases

Expression of adhesion factor CD239 in bone marrow cells in chronic myeloproliferative diseases

2008 ◽  
Vol 28 (3) ◽  
pp. 299-303
Author(s):  
Kais Hussein ◽  
Katharina Theophile ◽  
Katrin Denzer ◽  
Hans Kreipe ◽  
Oliver Bock
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Cells ◽  
Myeloproliferative Diseases ◽  
Adhesion Factor ◽  
Chronic Myeloproliferative Diseases ◽  
Marrow Cells

Hanover Classification of Chronic Myeloproliferative Diseases by Histopathology of the Bone Marrow

Leukemias ◽  
1993 ◽  
pp. 259-265
Author(s):  
A. George ◽  
K. F. Vykoupil ◽  
T. Buhr ◽  
M. Dominis ◽  
U. Döhler ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Myeloproliferative Diseases ◽  
Chronic Myeloproliferative Diseases

The Protective Role of Selenium Against AFB1-Induced Liver Apoptosis by Death Receptor Pathway in Broilers

2019 ◽  
Vol 191 (2) ◽  
pp. 453-463 ◽  
Author(s):  
Bangyuan Wu ◽  
Muhammad Jameel Mughal ◽  
Jing Fang ◽  
Xi Peng
Keyword(s):  
Death Receptor ◽  
Protective Role ◽  
Death Receptor Pathway
Sign in / Sign up

Export Citation Format

Share Document